Despite concerns about clinical outcomes for patients with obesity, clinical trials report few data about such patients.

These key steps are ones health sector stakeholders should take to help patients and clinicians use pricing information to inform health decision making.

For dying patients and their loved ones to make informed decisions, physicians must share adequate information about prognoses, prospective benefits and harms of specific interventions, and costs.

Online tools intended to make health care purchasing resemble “consumerism” have had little effect on improving transparency for patients.

Negative health consequences from costly care are referred to as financial toxicity and should be included in informed consent discussions.

Fragmentation in US health care delivery streams and shortcomings in formal quality measures mean that transparency could be more useful to policymakers and regulators than patients.

This article analyzes differences in prescription drug pricing transparency practices among 3 Organisation of Economic Co-operation and Development member nations.

This article applies principlism to what a “shoppable service” model would demand of clinicians in practice.

Scott Schweikart joins Ethics Talk to discuss his article: “AMA Code of Medical Ethics’ Opinions Related to Clinicians in Government.”

The adverse health effects of climate change should be the focus of physician advocacy efforts and of conversations between physicians and their patients.